Stockreport

Plus Therapeutics Announces Expansion of CNSide Team and Issuance of Inducement Grants

PLUS THERAPEUTICS, Inc.  (PSTV) 
PDF HOUSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targete [Read more]